These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1370607

  • 21. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase.
    Takishima K, Griswold-Prenner I, Ingebritsen T, Rosner MR.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2520-4. PubMed ID: 1848706
    [Abstract] [Full Text] [Related]

  • 22. Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor.
    Bertics PJ, Gill GN.
    J Biol Chem; 1985 Nov 25; 260(27):14642-7. PubMed ID: 2997217
    [Abstract] [Full Text] [Related]

  • 23. Aggregation of IGF-I receptors or insulin receptors and activation of their kinase activity are simultaneously caused by the presence of polycations or K-ras basic peptides.
    Xu QY, Li SL, LeBon TR, Fujita-Yamaguchi Y.
    Biochemistry; 1991 Dec 24; 30(51):11811-9. PubMed ID: 1661148
    [Abstract] [Full Text] [Related]

  • 24. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669.
    Northwood IC, Gonzalez FA, Wartmann M, Raden DL, Davis RJ.
    J Biol Chem; 1991 Aug 15; 266(23):15266-76. PubMed ID: 1651322
    [Abstract] [Full Text] [Related]

  • 25. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.
    Fan YX, Wong L, Johnson GR.
    Biochem J; 2005 Dec 15; 392(Pt 3):417-23. PubMed ID: 16122376
    [Abstract] [Full Text] [Related]

  • 26. Evidence that the epidermal growth factor receptor and non-tyrosine kinase hormone receptors stimulate phosphoinositide hydrolysis by independent pathways.
    Hepler JR, Jeffs RA, Huckle WR, Outlaw HE, Rhee SG, Earp HS, Harden TK.
    Biochem J; 1990 Sep 01; 270(2):337-44. PubMed ID: 1698055
    [Abstract] [Full Text] [Related]

  • 27. Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptors.
    Gronowski AM, Bertics PJ.
    Endocrinology; 1993 Dec 01; 133(6):2838-46. PubMed ID: 8243311
    [Abstract] [Full Text] [Related]

  • 28. Substrate specificities of tyrosine-specific protein kinases toward cytoskeletal proteins in vitro.
    Akiyama T, Kadowaki T, Nishida E, Kadooka T, Ogawara H, Fukami Y, Sakai H, Takaku F, Kasuga M.
    J Biol Chem; 1986 Nov 05; 261(31):14797-803. PubMed ID: 3771552
    [Abstract] [Full Text] [Related]

  • 29. Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation.
    Bertics PJ, Chen WS, Hubler L, Lazar CS, Rosenfeld MG, Gill GN.
    J Biol Chem; 1988 Mar 15; 263(8):3610-7. PubMed ID: 3346210
    [Abstract] [Full Text] [Related]

  • 30. Effect of protein kinase P on phosphorylations catalyzed by the epidermal growth factor.
    Abdel-Ghany M, Kole HK, Racker E.
    Proc Natl Acad Sci U S A; 1987 Dec 15; 84(24):8888-92. PubMed ID: 3501120
    [Abstract] [Full Text] [Related]

  • 31. Tyrosine-specific phosphorylation of calmodulin by the insulin receptor kinase purified from human placenta.
    Sacks DB, Fujita-Yamaguchi Y, Gale RD, McDonald JM.
    Biochem J; 1989 Nov 01; 263(3):803-12. PubMed ID: 2480780
    [Abstract] [Full Text] [Related]

  • 32. Cholesterol and phosphoinositides increase affinity of the epidermal growth factor receptor.
    den Hartigh JC, van Bergen en Henegouwen PM, Boonstra J, Verkleij AJ.
    Biochim Biophys Acta; 1993 Jun 05; 1148(2):249-56. PubMed ID: 8389198
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. BE-23372M, a novel and specific inhibitor for epidermal growth factor receptor kinase.
    Tanaka S, Okabe T, Chieda S, Endo K, Kanoh T, Okura A, Yoshida E.
    Jpn J Cancer Res; 1994 Mar 05; 85(3):253-9. PubMed ID: 8188523
    [Abstract] [Full Text] [Related]

  • 39. Antibody-induced activation of the epidermal growth factor receptor tyrosine kinase requires the presence of detergent.
    Spaargaren M, Defize LH, de Laat SW, Boonstra J.
    Biochem Biophys Res Commun; 1990 Sep 14; 171(2):882-9. PubMed ID: 2169740
    [Abstract] [Full Text] [Related]

  • 40. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
    Poppleton HM, Wiepz GJ, Bertics PJ, Patel TB.
    Arch Biochem Biophys; 1999 Mar 15; 363(2):227-36. PubMed ID: 10068444
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.